2012Hainan Yixueyuan xuebaoRequires access

Effect of azithromycin on mycoplasma pneumonia in children

XU Zhi-you

Open publisher page 0 citations

Abstract

Objective: To explore the clinical efficacy of azithromycin on the treatment of mycoplasma pneumonia in children.Methods:146 children aged 6 months to 15-year-old with mycoplasma pneumonia,were randomly divided into two groups.Children in the treatment group were treated by intravenous injection of azithromycin,10 mg/kg·d,1 time/d,6 days for a course;while children in the control group were treated by erythromycin,30-50 mg/kg·d,2 times/d,10 days for a course.Clinical efficacy was observed and compared.Results: Efficacy of the treatment group was more satisfactory than the control group,and the difference was significant(P 0.05);The incidence of gastrointestinal reactions of treatment group was significantly lower than the control group.Conclusions:Azithromycin is effective on mycoplasma pneumonia.It is the first choice,with long half-life and fewer adverse reactions.

About this research paper

What this paper is about

Objective: To explore the clinical efficacy of azithromycin on the treatment of mycoplasma pneumonia in children.Methods:146 children aged 6 months to 15-year-old with mycoplasma pneumonia,were randomly divided into two groups.Children in the treatment group were treated by intravenous injection of azithromycin,10 mg/kg·d,1 time/d,6 days for a course;while children in the control group were treated by erythromycin,30-50 mg/kg·d,2 times/d,10 days for a course.Clinical efficacy was observed and compared.Results: Efficacy of the treatment group was more satisfactory than the control group,and the difference was significant(P 0.05);The incidence of gastrointestinal reactions of treatment group was significantly lower than the control group.Conclusions:Azithromycin is effective on mycoplasma pneumonia.It is the first choice,with long half-life and fewer adverse reactions.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To explore the clinical efficacy of azithromycin on the treatment of mycoplasma pneumonia in children.Methods:146 children aged 6 months to 15-year-old with mycoplasma pneumonia,were randomly divided into two groups.Children in the treatment group were treated by intravenous injection of azithromycin,10 mg/kg·d,1 time/d,6 days for a course;while children in the control group were treated by erythromycin,30-50 mg/kg·d,2 times/d,10 days for a course.Clinical efficacy was observed and compared.Results: Efficacy of the treatment group was more satisfactory than the control group,and the difference was significant(P 0.05);The incidence of gastrointestinal reactions of treatment group was significantly lower than the control group.Conclusions:Azithromycin is effective on mycoplasma pneumonia.It is the first choice,with long half-life and fewer adverse reactions.

Key concepts: Azithromycin, Medicine, Mycoplasma pneumonia, Erythromycin, Pneumonia, Incidence (geometry), Clinical efficacy, Mycoplasma

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of azithromycin on mycoplasma pneumonia in children — Research Paper | ScholarLens